Quick Comparison

NAD+Vitamin B12
Half-LifeIV: effects persist 48-72 hours (2-3 days) | Oral precursors (NMN/NR): 2-4 hoursHepatic stores last years; circulating methylcobalamin: 144 hours (6 days)
Typical DosageIV: 250-1000 mg infusion over 2-4 hours, once or twice weekly. Oral precursors (NMN/NR): 250-1000 mg once daily. Intramuscular: 50-100 mg once daily. Sublingual: 100-250 mg once daily.Deficiency treatment: 1000 mcg intramuscular once weekly for 4-8 weeks, then 1000 mcg intramuscular once monthly for maintenance. Oral: 500-2000 mcg once daily. Sublingual: 1000-5000 mcg once daily. Pernicious anemia requires lifelong intramuscular injections.
AdministrationIntravenous infusion, intramuscular injection, or oral (NMN/NR precursors)Intramuscular injection, subcutaneous injection, oral, or sublingual
Research Papers30 papers30 papers
Categories

Mechanism of Action

NAD+

Nicotinamide Adenine Dinucleotide (NAD+) is a dinucleotide coenzyme consisting of nicotinamide mononucleotide (NMN) joined to adenosine monophosphate (AMP) through a pyrophosphate bond. It exists in oxidized (NAD+) and reduced (NADH) forms and participates in over 500 enzymatic reactions, making it one of the most central molecules in cellular metabolism.

As a redox cofactor, NAD+ accepts hydride ions (H-) during catabolic reactions. In glycolysis, the TCA cycle, and fatty acid beta-oxidation, NAD+ is reduced to NADH, which then donates electrons to Complex I of the mitochondrial electron transport chain, driving oxidative phosphorylation and ATP production. Without adequate NAD+, the entire energy production machinery of the cell grinds to a halt.

Equally important are NAD+'s roles as a consumed substrate for three families of signaling enzymes. Sirtuins (SIRT1-7) are NAD+-dependent protein deacylases and ADP-ribosyltransferases that use NAD+ as a co-substrate, cleaving it to nicotinamide and O-acetyl-ADP-ribose during the deacetylation reaction. SIRT1 and SIRT3 are particularly important for aging — SIRT1 deacetylates PGC-1α (activating mitochondrial biogenesis), FOXO transcription factors (activating stress resistance), and NF-κB (suppressing inflammation). SIRT3 in the mitochondrial matrix activates SOD2 and other mitochondrial enzymes. PARPs (poly-ADP-ribose polymerases) consume NAD+ during DNA damage repair, adding chains of ADP-ribose to histones near DNA breaks to recruit repair machinery. CD38, an NAD+-consuming glycohydrolase on immune cells, regulates calcium signaling and immune activation.

NAD+ levels decline 40-60% between ages 40 and 70, driven by increased CD38 expression (with chronic low-grade inflammation), increased PARP activity (from accumulated DNA damage), and reduced synthesis (decreased NAMPT enzyme activity). This decline impairs sirtuin function, reduces ATP production, compromises DNA repair, and contributes to virtually every hallmark of aging. Supplementation strategies aim to restore NAD+ levels either directly (IV infusion) or through biosynthetic precursors: NMN enters the salvage pathway one step from NAD+, while NR (nicotinamide riboside) requires an additional phosphorylation step.

Vitamin B12

Vitamin B12 (cobalamin) is a large organometallic molecule with a cobalt ion at its center, coordinated within a corrin ring. It is the most structurally complex vitamin and the only one containing a metal ion. Humans cannot synthesize B12 — it is produced exclusively by certain bacteria and archaea, and enters the human diet through animal products or bacterial fermentation. Absorption requires intrinsic factor (produced by gastric parietal cells), which binds B12 in the ileum for receptor-mediated endocytosis via the cubam receptor complex.

B12 functions as a cofactor for two essential enzymes. Methionine synthase (MS) uses methylcobalamin (methylB12) to catalyze the transfer of a methyl group from methyltetrahydrofolate (methyl-THF) to homocysteine, producing methionine and regenerating tetrahydrofolate (THF). This reaction sits at the intersection of two critical pathways: methionine is converted to S-adenosylmethionine (SAM), the universal methyl donor for DNA methylation, histone modification, neurotransmitter synthesis, and hundreds of other methylation reactions; and THF regeneration is essential for folate cycling and de novo nucleotide synthesis (required for DNA replication). B12 deficiency traps folate as methyl-THF ('methyl trap'), blocking DNA synthesis and causing megaloblastic anemia — red blood cell precursors cannot replicate their DNA properly, producing abnormally large, non-functional cells.

Methylmalonyl-CoA mutase uses adenosylcobalamin (adenosylB12) in mitochondria to convert methylmalonyl-CoA to succinyl-CoA, a key step in the catabolism of odd-chain fatty acids, branched-chain amino acids, and cholesterol. Deficiency causes methylmalonic acid accumulation, which is toxic to neurons and contributes to the peripheral neuropathy, subacute combined degeneration of the spinal cord, and cognitive decline seen in B12 deficiency. The neurological damage occurs because myelin synthesis requires both SAM-dependent methylation reactions (for phospholipid synthesis) and proper fatty acid metabolism (for myelin lipid composition), both of which depend on B12. Neurological damage from severe B12 deficiency can become irreversible if not treated promptly, which is why injectable B12 (which bypasses absorption barriers) is preferred for deficiency treatment.

Risks & Safety

NAD+

Common

flushing, nausea, chest tightness, anxiety during IV infusion, mild stomach upset with oral forms.

Serious

theoretical concern that NAD+ could fuel growth of existing cancers; rapid infusion can cause significant chest pressure and anxiety.

Rare

severe infusion reaction, irregular heartbeat with rapid IV push.

Vitamin B12

Common

injection site pain, brief diarrhea.

Rare

acne, allergic reactions to cyanocobalamin formulation, itching, blood clots.

Full Profiles